Combination therapy using antibody drug conjugates

The present disclosure relates to the combination of an anti-CD19 antibody drug conjugate and an anti-CD79b conjugate, and their use in therapy, such as the treatment of proliferative disorders. 本公开涉及抗CD19抗体药物缀合物与抗CD79b缀合物的组合，以及它们在治疗中的用途，诸如治疗增生性病症。...

Full description

Saved in:
Bibliographic Details
Main Authors VAN BERKEL, PETER, H., C, ZAMMARCHI, FRANCO
Format Patent
LanguageChinese
English
Published 27.02.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to the combination of an anti-CD19 antibody drug conjugate and an anti-CD79b conjugate, and their use in therapy, such as the treatment of proliferative disorders. 本公开涉及抗CD19抗体药物缀合物与抗CD79b缀合物的组合，以及它们在治疗中的用途，诸如治疗增生性病症。
Bibliography:Application Number: CN202280043390